Cerebral to pay nearly $3.7M over controlled substance prescribing practices

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Researchers seek to develop noninvasive diagnostics for chronic fatigue syndrome

Chronic fatigue syndrome (CFS) is a complex and long-term illness characterized by extreme fatigue that doesn’t improve with rest, and can worsen with physical activity.

November 21, 2024

The nursing staffing crisis has hit one role particularly hard: the nurse manager

Though the Covid-19 pandemic brought heightened attention to nurses overall, a unique nursing role has been long overlooked and, for the public, largely misunderstood: that

January 12, 2024

The privileged status of orphan medicines in Germany – Pharmaceutical Technology

Share this article To gain insight into this landscape, the number of orphan drugs assessed by the G-BA, their innovation rating, and price impact compared

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.